Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients

被引:0
|
作者
Kubisa, Michal Jan [1 ]
Wojtys, Malgorzata Edyta [2 ]
Lisowski, Piotr [2 ]
Kordykiewicz, Dawid [2 ]
Piotrowska, Maria [2 ]
Wojcik, Janusz [2 ]
Pierog, Jaroslaw [2 ]
Safranow, Krzysztof [3 ]
Grodzki, Tomasz [2 ]
Kubisa, Bartosz [4 ]
机构
[1] Carolina Hosp Luxmed, Dept Orthopaed Surg & Traumatol, PL-02757 Warsaw, Poland
[2] Pomeranian Med Univ, Dept Thorac Surg & Transplantat, PL-70880 Szczecin, Poland
[3] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70111 Szczecin, Poland
[4] Warsaw Med Univ, Dept Cardiac Thorac & Transplantat Surg, PL-02097 Warsaw, Poland
关键词
PGD; lung transplantation; CVP; CENTRAL VENOUS-PRESSURE; ISHLT WORKING GROUP; INTERNATIONAL-SOCIETY; ISCHEMIC TIME; HEART; SURVIVAL; DEFINITION; INCREASES; STATEMENT; OUTCOMES;
D O I
10.3390/clinpract14040127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Primary graft dysfunction (PGD) is a form of acute lung injury (ALI) that occurs within 72 h after lung transplantation (LuTx) and is the most common early complication of the procedure. PGD is diagnosed and graded based on the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen and chest X-ray results. PGD grade 3 increases recipient mortality and the chance of chronic lung allograft dysfunction (CLAD). Method: The aim of this retrospective study was to identify new PGD risk factors. The inclusion criteria were met by 59 patients, who all received transplants at the same center between 2010 and 2018. Donor data were taken from records provided by the Polish National Registry of Transplantation and analyzed in three variants: PGD 1-3 vs. PGD 0, PGD 3 vs. PGD 0 and PGD 3 vs. PGD 0-2. Results: A multiple-factor logistic regression model was used to identify decreasing recipient age; higher donor BMI and higher donor central venous pressure (CVP) for the PGD (of the 1-3 grade) risk factor. Conclusions: Longer cold ischemia time (CIT) and higher donor CVP proved to be independent risk factors of PGD 3.
引用
收藏
页码:1571 / 1583
页数:13
相关论文
共 50 条
  • [41] Redefining Primary Graft Dysfunction after Lung Transplantation
    Cantu, E.
    Diamond, J.
    Nellen, J.
    Beduhn, B.
    Suzuki, Y.
    Borders, C.
    Lasky, J.
    Schaufler, C.
    Shah, R.
    Porteous, M.
    Lederer, D. J.
    Kawut, S. M.
    Arcasoy, S.
    Palmer, S. M.
    Snyder, L.
    Hartwig, M. G.
    Lama, V. N.
    Crespo, M.
    Wille, K.
    Orens, A.
    Shah, P. D.
    Weinacker, A.
    Ware, L. B.
    Bellamy, S. L.
    Christie, J. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S89 - S89
  • [42] Immunopathogenesis of Primary Graft Dysfunction After Lung Transplantation
    Bharat, Ankit
    Kreisel, Daniel
    ANNALS OF THORACIC SURGERY, 2018, 105 (03): : 671 - 674
  • [43] Risk Factors for Primary Graft Dysfunction after Heart Transplantation - A Systematic Review and Meta-Analysis
    Vervoorn, M.
    Dengler, S. Kaffka Genaamd
    Mishra, J.
    Van der Kaaij, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S147 - S148
  • [44] Extracorporeal membrane oxygenation (ECMO) for primary graft dysfunction (PGD) after lung transplantation: Analysis of the extracorporeal life support organisation (ELSO) registry
    Fischer, S.
    Bohn, D.
    Rycus, P.
    Pierre, A. F.
    de Perrot, M.
    Waddell, T. K.
    Keshavjee, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S124 - S124
  • [45] Recipient, Surgical, and Donor Factors Leading to Primary Graft Dysfunction Following Lung Transplantation
    Toyoda, T.
    Manerikar, A.
    Kandula, V.
    Bharat, A.
    Kurihara, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S293 - S293
  • [46] Soluble P-Selectin and the Risk of Primary Graft Dysfunction after Lung Transplantation
    Kawut, S. M.
    Okun, J.
    Lederer, D. J.
    Ware, L. B.
    Lama, V.
    Welnacker, A.
    Demissie, E.
    Christie, J. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S309 - S309
  • [47] Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
    Shah, R. J.
    Diamond, J. M.
    Cantu, E.
    Flesch, J.
    Lee, J. C.
    Lederer, D. J.
    Lama, V. N.
    Orens, J.
    Weinacker, A.
    Wilkes, D. S.
    Roe, D.
    Bhorade, S.
    Wille, K. M.
    Ware, L. B.
    Palmer, S. M.
    Crespo, M.
    Demissie, E.
    Sonnet, J.
    Shah, A.
    Kawut, S. M.
    Bellamy, S. L.
    Localio, A. R.
    Christie, J. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (08) : 2188 - 2196
  • [48] Soluble P-Selectin and the Risk of Primary Graft Dysfunction After Lung Transplantation
    Kawut, Steven M.
    Okun, Jeffrey
    Shimbo, Daichi
    Lederer, David J.
    De Andrade, Joao
    Lama, Vibha
    Shah, Ashish
    Milstone, Aaron
    Ware, Lorraine B.
    Weinacker, Ann
    Demissie, Ejigayehu
    Christie, Jason D.
    CHEST, 2009, 136 (01) : 237 - 244
  • [49] Primary Graft Dysfunction (PGD) vs Transfusion-Related Lung Injury (TRLI) in Lung Transplantation (LT): Can These Entities Be Differentiated Based on the Current ISHLT PGD Definition?
    Crespo, M. M.
    Clancy, C. J.
    Pilewski, J. M.
    Bermudez, C.
    Jarido, V.
    Johnson, B.
    Haider, S. S.
    Bhama, J.
    Toyoda, Y.
    Morrell, M.
    Shigemura, N.
    Nguyen, M. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S248 - S248
  • [50] Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation
    Li, David
    Weinkauf, Justin
    Kapasi, Ali
    Hirji, Alim
    Varughese, Rhea
    Lien, Dale
    Nagendran, Jayan
    Halloran, Kieran
    RESPIRATORY MEDICINE, 2021, 188